Abstract
Retrospective review of presentation, treatment and outcome of male breast cancer in a tertiary cancer centre in eastern India. Data of 42 male breast cancer (MBC) patients, who presented between April, 2001 and March, 2008 were collected from institute records with respect to epidemiological characteristics, clinical and pathological parameters, treatment pattern and outcome. This series includes 42 patients with mean age of 56 years (range 31–78 years). MBC represented 1.1 % of all breast cancer. History of lump in the breast with duration ranging from 1 month to 4 years was the most common clinical presentation (80.95 %). Histopathology found infiltrating ductal carcinoma in 35 (83.33 %), followed by papillary carcinoma in 3 (7.14 %), undifferentiated carcinoma in 2 (4.76 %), mucinous carcinoma in 1 (2.38 %) and myxofibrosarcoma in 1 (2.38 %) patient. Hormone receptor (HR) study was performed on 29 patients. Twenty six (89.7 %) patients were hormone receptor positive in that 8 (27.6 %) were ER positive and 18 (62.1 %) were ER and PR positive. 3 (10.3 %) were hormone receptor negative.Axillary lymph node dissection was performed on 30 patients. Of those, 60 % were found to be positive (pN+) and 40 % were negative (pN-). Of the patients with invasive carcinoma 2.86 % were pathologic stage I, 37.14 % stage II, 42.86 % stage III and 17.14 % stage IV. Of the 35 treated patients, total 30 (85.71 %) patients underwent surgery. The surgery consisted of a modified radical mastectomy (MRM) 24 (80 %), radical mastectomy according to Halsted (RM) 6 (20 %). Adjuvant therapy i.e. Chemotherapy and Radiotherapy was administered to the patient based upon their stage. The standard treatment for all HR positive patients was administration of tamoxifen. Based upon the follow-up information (ranging from 17 month to 136 months), 4 (14.28 %) patients developed local recurrence over 4 to 26 months (mean17.5 months) and 5 patients developed distant metastasis over 24 to132 months (mean 78 months). Disease specific survival varied from 4 months to 132 months, with a mean of 56.75 months. Thirteen out of 28 evaluable patients (46.43 %) were disease free at 5 years. Male Breast cancer is a rare disease often ignored in the community, because of which it is seeks medical attention at advanced stage. Majority of MBC are found to be HR positive, hence hormonal therapy should to be strongly considered and multicentric prospective studies are needed to improve outcome.
Similar content being viewed by others
References
Redlich PN, Donegan WL (2000) Carcinoma of the breast in men. In: Winchester DJ, Winchester DP, Decker BC (eds) American Cancer Society Atlas of Clinical Oncology Breast Cancer. Inc Hamilton, London, pp 239–252
Bagley CS, Wesley MN, Young RC et al (1987) Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol 10:55–60
Giordano SH (2005) A review of diagnosis and management of male breast cancer. Oncologist 10:471–479
Applebaum AH, Evans GF, Levy KR et al (1999) Radiographics 19:559–568
Field KM, Campbell B, De Boer R (2008) Male breast cancer: Progress, prognosis and future pathways. Asia Pac J ClinOncol 4:6–17
Contractor KB, Kaur K, Rodrigues GS (2008) Male breast cancer: Is the scenario changing? World J Surg Oncol. doi:10.1186/1477-7819-6-58
Giordano SH, Cohen DS, Buzdar AU et al (2004) Breast carcinoma in men: A population based study. Cancer 101:51–57
Goss PE, Reid C, Pintilie M et al (1999) Male breast carcinoma. Cancer 85:629–639
Erlichman C, Murphy KC, Elkahim T (1984) Male breast cancer: A 13 year review of 89 patients. J ClinOncol 2:903–909
Schieke O, Agarwal A, Ayatunde AA, Rampaul R, Robertson JFR (2007) Male breast cancer: A review of clinical management. Breast Canc Res Treat 103:11–21
Borgen PI, Wong GI, Vlamis V et al (1992) Current management of male breast cancer: A review of 104 cases. Ann Surg 215:451–459
Giordano SH, Buzdar AU, Hortobagyi GN et al (2002) Breast cancer in men. Ann Intern Med 137:678–687
Borgen PI, Senie RT, McKinnon WMP et al (1997) Carcinoma of the male breast: Analysis of prognosis compared to matched female patients. Ann Surg Oncol 4:385–389
Doyen J, Italiano A, Largillier R et al (2010) Aromatase inhibition in male breast cancer patients: Biological and clinical implications. Ann Oncol 21:1243–1245
Hinrichs CS, Watroba NL, Rezaishiraz H et al (2004) Lymphedema secondary to postmastectomy radiation: Incidence and risk factors. Ann Surg Oncol 11:573–580
El-Tamer MB, Komaneka IK, Troxel A (2004) Men with breast cancer has better disease-specific survival than women. Arch Surg 139:1079–1082
Anderson WF, Jatoi I, Tse J, Rosenberg PS (2010) Male breast cancer: A population based comparison with female breast cancer. J Clin Oncol 28:232–239
Komaneka IK, Miller KD, Sledge WG Jr (2006) Male breast cancer. In Raghavan D, Brecher ML, Johnson DH et al. (ed) Textbook of uncommon cancer, 3rd edn. John Wiley & Sons 201–208
Atahan L, Yidiz F, Selek U et al (2006) Perioperative radiotherapy in the treatment of male breast carcinoma; a single institution experience. J Natl Med Assoc 98:559–563
Vetto JT (2010) Breast diseases in males. In Jatoi I, Kaufmann M (ed) Management of breast diseases, Springer-Verlag. 471–496
Scott-Conner CE, Jochimsen PR, Menck HR et al (1999) An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery 126:775–780
Walshe JM, Berman AW, Vatas U et al (2007) A prospective study of adjuvant CMF in males with node positive breast cancer: 20 year follow-up. Breast Canc Res Treat 103:177–183
Giordino S, Perkins GH, Broglio K et al (2005) Adjuvant systemic therapy for male breast cancer. Cancer 104:2359–2364
Agrawal A, Ayantunde AAA, Rampaul R, Robertson JFR (2007) Male breast cance: A review of clinical management. Breast Canc Res Treat 103:11–21
Farrow J, Adair F (1942) Effect of orchiectomy on skeletal metastases from cancer of the male breast. Science 95:654–657
Volm MD (2003) Male breast cancer. Curr Treat Options Oncol 4:159–164
Vinod SK, Pendlebury SC (1999) Cancer of the male breast: A review of adjuvant therapy. Australas Radiol 43:69–72
Borgen PI, Wong GY, Vlamis V (1992) Current management of male breast cancer: A review of 104 cases. Ann Surg 215:451–457
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shah, S., Bhattacharyya, S., Gupta, A. et al. Male Breast Cancer: A Clinicopathologic Study of 42 Patients in Eastern India . Indian J Surg Oncol 3, 245–249 (2012). https://doi.org/10.1007/s13193-012-0163-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-012-0163-1